These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19591526)

  • 1. Medication problems in older, newly diagnosed cancer patients in Canada: How common are they? A prospective pilot study.
    Puts MT; Costa-Lima B; Monette J; Girre V; Wolfson C; Batist G; Bergman H
    Drugs Aging; 2009; 26(6):519-36. PubMed ID: 19591526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential medication problems in older newly diagnosed cancer patients in Canada during cancer treatment: a prospective pilot cohort study.
    Puts MT; Monette J; Girre V; Costa-Lima B; Wolfson C; Batist G; Bergman H
    Drugs Aging; 2010 Jul; 27(7):559-72. PubMed ID: 20583850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of older newly diagnosed cancer patients refusing cancer treatments.
    Puts MT; Monette J; Girre V; Wolfson C; Monette M; Batist G; Bergman H
    Support Care Cancer; 2010 Aug; 18(8):969-74. PubMed ID: 20419496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug interactions and duplicate prescriptions among cancer patients.
    Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
    J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy and drug interactions in older patients with cancer receiving chemotherapy: associated factors.
    Oliveira RF; Oliveira AI; Cruz AS; Ribeiro O; Afreixo V; Pimentel F
    BMC Geriatr; 2024 Jun; 24(1):557. PubMed ID: 38918696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions.
    Tulner LR; Kuper IM; Frankfort SV; van Campen JP; Koks CH; Brandjes DP; Beijnen JH
    Am J Geriatr Pharmacother; 2009 Apr; 7(2):93-104. PubMed ID: 19447362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy.
    Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C
    Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-study).
    Verdoorn S; Kwint HF; Blom JW; Gussekloo J; Bouvy ML
    PLoS Med; 2019 May; 16(5):e1002798. PubMed ID: 31067214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study.
    Puts MT; Monette J; Girre V; Wolfson C; Monette M; Batist G; Bergman H
    Crit Rev Oncol Hematol; 2010 Nov; 76(2):142-51. PubMed ID: 19939699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients.
    Umar RM; Apikoglu-Rabus S; Yumuk PF
    Int J Clin Pharm; 2020 Apr; 42(2):652-661. PubMed ID: 32078106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence study on potential drug-drug interaction in cancer patients in Piacenza hospital's Onco-Haematology department.
    Vecchia S; Orlandi E; Confalonieri C; Damonti E; Riva A; Sartori A; Cavanna L
    J Oncol Pharm Pract; 2018 Oct; 24(7):490-493. PubMed ID: 28714379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
    Loya AM; González-Stuart A; Rivera JO
    Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and the management of the older cancer patient.
    Balducci L; Goetz-Parten D; Steinman MA
    Ann Oncol; 2013 Oct; 24 Suppl 7(Suppl 7):vii36-40. PubMed ID: 24001761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of self-rated health with functional status, toxicity and mortality: results of a prospective pilot study of older patients with newly-diagnosed cancer.
    Puts M; Monette J; Girre V; Sourial N; Wolfson C; Monette M; Batist G; Bergman H
    J Geriatr Oncol; 2013 Oct; 4(4):319-26. PubMed ID: 24472474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A medication review and deprescribing method for hospitalised older patients receiving multiple medications.
    McKean M; Pillans P; Scott IA
    Intern Med J; 2016 Jan; 46(1):35-42. PubMed ID: 26387783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of drug-related problems in three departments of a German University hospital.
    Lenssen R; Heidenreich A; Schulz JB; Trautwein C; Fitzner C; Jaehde U; Eisert A
    Int J Clin Pharm; 2016 Feb; 38(1):119-26. PubMed ID: 26511945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.
    Nightingale G; Hajjar E; Swartz K; Andrel-Sendecki J; Chapman A
    J Clin Oncol; 2015 May; 33(13):1453-9. PubMed ID: 25800766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.